The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity
Open accessAbstract
IMPORTANCE: Although metabolic surgery (defined as procedures that influence metabolism by inducing weight loss and altering gastrointestinal physiology) significantly improves cardiometabolic risk factors, the effect on cardiovascular outcomes has been less well characterized. OBJECTIVE: To investigate the relationship between metabolic surgery and incident major adverse cardiovascular events (MACE) in patients with type 2 diabetes and obesity. DESIGN, SETTING, AND PARTICIPANTS: Of 287 438 adult patients with diabetes in the Cleveland Clinic Health System in the United States between 1998 and 2017, 2287 patients underwent metabolic surgery. In this retrospective cohort study, these patients were matched 1:5 to nonsurgical patients with diabetes and obesity (body mass index [BMI] ≥30), resulting in 11 435 control patients, with follow-up through December 2018. EXPOSURES: Metabolic gastrointestinal surgical procedures vs usual care for type 2 diabetes and obesity. MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of extended MACE (composite of 6 outcomes), defined as first occurrence of all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation. Secondary end points included 3-component MACE (myocardial infarction, ischemic stroke, and mortality) and the 6 individual components of the primary end point. RESULTS: Among the 13 722 study participants, the distribution of baseline covariates was balanced between the surgical group and the nonsurgical group, including female sex (65.5% vs 64.2%), median age (52.5 vs 54.8 years), BMI (45.1 vs 42.6), and glycated hemoglobin level (7.1% vs 7.1%). The overall median follow-up duration was 3.9 years (interquartile range, 1.9-6.1 years). At the end of the study period, 385 patients in the surgical group and 3243 patients in the nonsurgical group experienced a primary end point (cumulative incidence at 8-years, 30.8% [95% CI, 27.6%-34.0%] in the surgical group and 47.7% [95% CI, 46.1%-49.2%] in the nonsurgical group [P < .001]; absolute 8-year risk difference [ARD], 16.9% [95% CI, 13.1%-20.4%]; adjusted hazard ratio [HR], 0.61 [95% CI, 0.55-0.69]). All 7 prespecified secondary outcomes showed statistically significant differences in favor of metabolic surgery, including mortality. All-cause mortality occurred in 112 patients in the metabolic surgery group and 1111 patients in the nonsurgical group (cumulative incidence at 8 years, 10.0% [95% CI, 7.8%-12.2%] and 17.8% [95% CI, 16.6%-19.0%]; ARD, 7.8% [95% CI, 5.1%-10.2%]; adjusted HR, 0.59 [95% CI, 0.48-0.72]). CONCLUSIONS AND RELEVANCE: Among patients with type 2 diabetes and obesity, metabolic surgery, compared with nonsurgical management, was associated with a significantly lower risk of incident MACE. The findings from this observational study must be confirmed in randomized clinical trials. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03955952.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After surgery, the significant improvement of metabolic disease, as well as the decrease in overall mortality, has been reported in multiple studies further supporting the importance of this treatment modality [15–19].”
The cited source says what the claim attributes to it.
In the citing paper
“After surgery, the significant improvement of metabolic disease, as well as the decrease in overall mortality, has been reported in multiple studies further supporting the importance of this treatment modality [15–19].”
In the citing paper
“Indeed, marked weight loss achieved through bariatric surgery is associated with improvements in glucose levels and cardiac structure and function in patients with obesity and T2DM.14, 15, 16”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [14]
In the citing paper
“In a recently published retrospective cohort study, a substantial reduction in all-cause mortality and incident cases of major adverse cardiovascular events such as coronary artery events, cerebrovascular events, nephropathy, heart failure and atrial fibrillation was noted in those who had bariatric surgery [62].”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
(2010) · University of Twente Research Information · Cited by 6,037
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Self-citationCardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 505
Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified
Halpern, B., & Mancini, M. C. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01603-8 · Cited by 4
de Oliveira, G. S., Maia, R. P., Gamba, P. B. B., Figueiredo, A. C. M. G., & de Carvalho, K. M. B. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07792-x · Cited by 3
“It is well-established in the literature that MBS offers significant advantages over non-surgical methods in terms of weight loss, improvements in metabolic diseases, and reductions in overall mortality rates [4–6].”
Bariatric Surgery in the Era of GLP1RA: A Narrative Review
Muhundan, M., & Dash, S. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03494-7 · Cited by 3
Barriers to metabolic surgery and how to address them
Laville, M., Robert, M., & Segrestin, B. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155764 · Cited by 3
Metabolic-Bariatric Surgery for Type 2 Diabetes: Time(ing) for a Change
Purnell, J. Q. (2024) · Diabetes · doi:10.2337/dbi23-0022 · Cited by 3
Vahtera, V., Pajarinen, J., Mika Kivimaki, B., Ervasti, J. M., Pentti, J., Stenholm, S., Vahtera, J., & Salminen, P. T. P. (2024) · British journal of surgery · doi:10.1093/bjs/znae105 · Cited by 3
“Metabolic bariatric surgery (MBS) has been established as the most effective treatment for severe obesity, often resulting in sustainable weight loss and remission of obesity-related co-morbidities 7–9 .”
BackgroundCarmo‐Silva, S., & Nóbrega, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-62491-9_2 · Cited by 3
An Evaluation of Primary Care Clinician Referrals for Behavioral Weight Loss Counseling
Saraiya, V., Berkowitz, S. A., Johnston, L. F., Couper, D. J., Sotres‐Alvarez, D., Lyons, K. M., Thaxton, C. K., Skinner, H. G., Samuel‐Hodge, C. D., & Keyserling, T. C. (2024) · Journal of Primary Care & Community Health · doi:10.1177/21501319241308054 · Cited by 3
Lin, Y., Yi, C., Cao, P., Lin, J., Chen, W., Mao, H., Yang, X. F., & Guo, Q. (2025) · Hypertension Research · doi:10.1038/s41440-025-02142-x · Cited by 3
Obesity is more than a number: a framework for treatment
COHEN, R. V., Prager, G., & Salminen, P. T. P. (2025) · British journal of surgery · doi:10.1093/bjs/znaf100 · Cited by 3
Han, X., Pang, L., Zhang, X., Gao, H., Guo, H., Wang, W., Feng, H., Gu, J., & Wang, G. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16475 · Cited by 3
“Aminian et al. (2019) 6 demonstrated that metabolic surgery is not only associated with significant improvements in glycaemic control but also with a substantial reduction in major adverse cardiovascular events among obese patients with T2DM.”
Implications of Metabolic Bariatric Surgery on Reproductive Health
Rottenstreich, A., & Graham, Y. N. H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155446 · Cited by 3
“Metabolic and bariatric surgery (MBS) has become the most effective treatment for severe and complex obesity, due to its established efficacy in achieving significant weight loss and improving obesity-related health complications and quality of life [3–5].”
Sex Differences of Kidney Stone Urine Risk Factors after Roux-en-Y Gastric Bypass
Prochaska, M., Asplin, J. R., Chapman, A. B., & Worcester, E. M. (2021) · American Journal of Nephrology · doi:10.1159/000514455 · Cited by 3
Bias in electronic health record ‐based studies: Seeing the forest for the trees
Arterburn, D. E., Aminian, A., Nissen, S. E., Schauer, P. R., & Haneuse, S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14403 · Cited by 3
“cardiovascular benefit in prior electronic health record (EHR)-based observational studies.(2,3) Specifically, they consider the potential roles of confounding bias, which arises when treatment assignment is not”
BackgroundSelf-citationThe impact of bariatric surgery on the risk of coronary revascularization
Noubani, M., Zhang, X., Yang, J., Powers, K. A., Spaniolas, K., & Pryor, A. D. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.01.013 · Cited by 3
Bariatric Surgery - Past and Present
Kanat, B. H., Kutluer, N., & Doğan, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100966 · Cited by 2
Sachan, A., Aggarwal, S., Pol, M. M., Singh, A., & Yadav, R. (2023) · Clinical Obesity · doi:10.1111/cob.12607 · Cited by 6
“than visceral depots.(19) The structural reorganization of these collagens in adipose compartment”
BackgroundItalian Association of Hospital Cardiologists position paper—obesity in adults: a clinical primer
Fusco, S. A. D., Mocini, E., Gori, M., Iacoviello, M., Bilato, C., Corda, M., Luca, L. D., Marco, M. D., Geraci, G., Iacovoni, A., et al. (2024) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suae031 · Cited by 3
“93,94 Target to achieve Obesity treatment aims to induce changes that enhance quality of life, mitigate associated comorbidities, and reduce mortality risk.”
BackgroundSio, Y.-C., Chen, C., Huang, Y.-M., Lee, W.-J., Hur, K. Y., Kasama, K., Cheng, A. K. S., Lee, M.-H., Simon, K. W., Soong, T., et al. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae260 · Cited by 3
“Such surgical procedures are reported to enhance glucose homeostasis through various mechanisms, including alterations in gut hormones, bile acid metabolism, the microbiota, and glucose metabolism within the gut [9 ].”
BackgroundInfluentialDiabetes Update 2020: das Wichtigste für die ärztliche Praxis
Scherbaum, W. A. (2020) · Der Diabetologe · doi:10.1007/s11428-020-00642-7 · Cited by 3
The Caprini Risk Score for Early Prediction of Mortality in Patients With Acute Coronary Syndrome
Li, W., Wang, Y., Li, D., Jia, Y., Li, F., Chen, T., Liu, Y., Zeng, Z., Wan, Z., Zeng, R., et al. (2022) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000949 · Cited by 3
Bulsei, J., Carandina, S., Zulian, V., Fontas, É., & Iannelli, A. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002870 · Cited by 2
“3-6 ] While most research on the topic has focused on solid tumors, indicating that MBS plays a protective role against the development of certain types of cancers and reduces cancer-related mortality, [4] evidence on the effects of MBS on hematological cancer remains limited.”
Müller, O., Marciniak, C., Lenne, X., Chouraki, V. A., Baud, G., Gobert, M., Vermeire, J., Chetboun, M., Verkindt, H., Bruandet, A., et al. (2025) · Annals of Surgery · doi:10.1097/sla.0000000000006881 · Cited by 2
Finn, A., Cedillo, Y. E., Aukan, M. I., Gower, B. A., & Martins, C. (2025) · Obesity · doi:10.1002/oby.70049 · Cited by 2
Ding, R., Elmadhoun, O., Chen, R., & Ji, X. (2025) · Brain Circulation · doi:10.4103/bc.bc_15_25 · Cited by 4
“[48] A retrospective cohort of obese patients (class II with comorbidities or class III) also reported that those who underwent weight loss surgery had a much lower risk of cerebrovascular events compared to the matched nontreated group.”
Tolvanen, L., Mossberg, K., Grace, L. M., Standen, E. C., Phelan, S. M., Andersson, D. P., & Koball, A. M. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08408-0 · Cited by 2
Huang, Y. S., Wen, J., wang, S., Song, Y., Zhou, B., Zhang, N., & Meng, H. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08748-5 · Cited by 4
“Metabolic and bariatric surgery (MBS) is the most effective and recommended treatment for patients with class II-III obesity [ 4], achieving substantial and sustained weight loss, along with improvements in comorbidities and quality of life, and increased life expectancy [ 5, 6 ].”
Ahmad, Y., Wasan, R., Perchik, J. D., & Nanda, N. C. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124430 · Cited by 2
“Metabolic surgery confers an improved risk of mortality as well [133].”
Radu, R. I., Davison, B. A., Collins, S. P., Mebazaa, A., Savarese, G., Miró, Ò., Morishetty, P., Geavlete, O. D., Volterrani, M., Edwards, C., et al. (2026) · Cardiac failure review · doi:10.15420/cfr.2025.56 · Cited by 2
Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease
Ferdinand, K. C., Ali, A., & Echols, M. R. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_20 · Cited by 2
Kim, B. K., & Seo, K. W. (2022) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2022.11.2.13 · Cited by 3
“[25] Retrospective cohort study The Cleveland Clinic Health System in the United States between 1998 and 2017, 2,287 patients underwent metabolic surgery, and matched 1:5 to non-surgical patients with diabetes and obesity 3-point MACE at 8-years, 30.”
MethodWildisen, A., Peterli, R., Werder, G., Müeller, B., Schüetz, P., Kaegi-Braun, N., & Kutz, A. (2023) · Annals of Surgery Open · doi:10.1097/as9.0000000000000286 · Cited by 2
Esparham, A., Roohi, S., Moghaddam, A. A., Moghadam, H. A., Shoar, S., & Khorgami, Z. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.04.010 · Cited by 2
Almuallem, S., Ali, A. K., Vourtzoumis, P., Demyttenaere, S. V., Court, O., & Andalib, A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15647 · Cited by 2
Katsoulis, M., Leyrat, C., Hingorani, A. D., & Gomes, M. (2024) · Epidemiology · doi:10.1097/ede.0000000000001766 · Cited by 2
“…design and analysis of previous observational studies conducted on this topic, which found overall that bariatric surgery lowers the risk of CVD. 2,3 In particular, a central limitation of those studies was the consideration of bariatric surgery as a “point intervention,” overlooking the…”
ResultObesity in Heart Failure with Reduced Ejection Fraction
Amdahl, M. B., Sundaram, V., & Reddy, Y. N. V. (2024) · Heart Failure Clinics · doi:10.1016/j.hfc.2024.06.006 · Cited by 2
Carandina, S., Ferro, S., Palma, M. D., Sartori, A., Zulian, V., & Iannelli, A. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002874 · Cited by 2
Haneuse, S., Benz, L., Smith, V. A., Arterburn, D. E., & Maceijewski, M. L. (2026) · Epidemiology · doi:10.1097/ede.0000000000001952 · Cited by 2
Self-citationShamsi, N. (2021) · Journal of Endocrinology and Metabolism Research · doi:10.37191/mapsci-2582-7960-2(2)-019 · Cited by 1
Lu, Y., Wu, V. C., Chu, P., Ho, C.-T., & Chang, C.-Y. (2021) · Medicine · doi:10.1097/md.0000000000028114 · Cited by 2
Current and Potential Applications of Artificial Intelligence in Metabolic Bariatric Surgery
Pantelis, A. G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106365 · Cited by 2
Yun, H., Joo, Y. S., Chang, T. I., Kang, E. W., Son, N., Kim, H. W., Park, J. T., Yoo, T., Kang, S., & Han, S. H. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110193 · Cited by 2
Aminian, A., Wilson, R. L., Zajichek, A., Tu, C., Wolski, K., Schauer, P. R., Kattan, M. W., Nissen, S. E., & Brethauer, S. A. (2021) · doi:10.2337/figshare.15173139.v1 · Cited by 2
Self-citationPoirier, P. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.12.037 · Cited by 2
Roux-en-Y gastric bypass: influence on adipose tissue and metabolic homeostasis
Menzel, C. P., Flynn, C. R., & English, W. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822186-0.00001-8 · Cited by 1
Valera, R. J., Sarmiento-Cobos, M. F., Montorfano, L. M., Patnaik, R., Liang, H., Menzo, E. L., Szomstein, S., & Rosenthal, R. J. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.04.327 · Cited by 1
Metabolic and Bariatric Surgery in Diabetes Management
Valadez, L. Z. M., Frigolet, M. E., Domínguez, R. M., Pescarus, R., Zerrweck, C., Boudreau, V., Doumouras, A. G., Cookson, T. A., & Anvari, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_42 · Cited by 1
Mackenzie, R. M., Ali, A., Bruce, D. M., Bruce, J., Ford, I., Greenlaw, N., Grieve, E., Lean, M. E. J., Lindsay, R. S., O’Donnell, J., et al. (2024) · Health Technology Assessment · doi:10.3310/unaw6331 · Cited by 1
Bariatric surgeries and cardiac structure and function: Systematic review and network meta‐analysis
Zhang, X., Chen, K., Zhang, Z., Zhang, N., Zheng, F., Zhou, B., Meng, H., Zhang, Z., & Niu, W. (2024) · Obesity Reviews · doi:10.1111/obr.13843 · Cited by 1
Surgical Strategies for the Management of Obesity
Au, C., Brumer, R. P., Schröer, J., & Tariq, N. (2025) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1513 · Cited by 2
Cost-effectiveness analysis of bariatric surgery in obese patients
Matrenin, К. I., Олеговна, К. Е., Khatsiev, B. B., Терян, Р. А., & Валерьевич, С. И. (2025) · Medical Technologies Assessment and Choice · doi:10.17116/medtech20254701162 · Cited by 1
Ostrominski, J. W., Aroda, V. R., Braae, U. C., Kruse, C., Mandavya, K., & Buse, J. B. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01751-6 · Cited by 2
“Although not investigated in this study, weight management through metabolic surgery has also been associated with a reduced need for glucose-and blood-pressure-lowering therapies [27], suggesting that modification of disease trajectory in obesity may reduce poly-pharmacy.”
Pregnancy Outcomes After One Anastomosis Gastric Bypass
Rottenstreich, A., Elazary, R., Ben‐Porat, T., Dagan, S. S., Beglaibter, N., & Grinbaum, R. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08006-0 · Cited by 2
“Metabolic and bariatric surgery (MBS) has become the mainstay of treatment for severe obesity, due to its established efficacy in achieving significant weight loss and improving obesity-related comorbidities and quality of life [3–5].”
Hönes, F., Mihaljević, A. L., Wulff, D., Archid, R., & Capobianco, I. (2025) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-025-03755-z · Cited by 1
The effect of weight change on death and cardiovascular events after Roux-en-Y gastric bypass
Stenberg, E., Näslund, E. B., Cao, Y., Ottosson, J., & Näslund, I. (2025) · British journal of surgery · doi:10.1093/bjs/znaf170 · Cited by 1
Lee, Y., Nguyen, F., Anvari, S., Molnar, A. O., Doumouras, A. G., Walsh, M. W., & Hong, D. (2025) · British journal of surgery · doi:10.1093/bjs/znaf168 · Cited by 1
Akwe, J. A., Fongeh, K., Jung, S. A., Hall, M. A. K., Patidar, V., & Shin, Y. M. (2025) · Cureus · doi:10.7759/cureus.91677 · Cited by 3
“…diastolic blood pressure [8] Decrease in LDL and triglycerides and increase in HDL [8] Improvement in metabolic syndrome and cardiovascular events [76] Quality of life (QoL) post-intervention Improvements in overall QoL with better mobility, self-care, decrease in pain although mental health…”
Hany, M., Elmongui, E., & Ansari, W. E. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08321-6 · Cited by 1
Preoperative endoscopy in revisional bariatric surgery: who should hold the scope?
Carandina, S., Avallone, S., Zulian, V., Angrisani, F., Angrisani, L., & Iannelli, A. (2025) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2025.102303 · Cited by 2
Li, Z.-Y., Kao, C., Liu, M., Hung, K., Lai, C., Lin, Y., & Wu, J. (2025) · World Journal of Surgery · doi:10.1002/wjs.70210 · Cited by 1
de León‐Ballesteros, G. P., Rodríguez-López, C., Martínez-Castro, S., Padrón, C. J. P. , Garcia-Govea, F., Garza-Torres, C., Gutiérrez-Rojas, C. A., López-Ortega, A., Meza-Jasso, M. A., Ortíz-Gómez, J. E., et al. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08617-1 · Cited by 1
Kamar, M. C., Coello, P. E. A., dos Santos, A. V. R., & Melo, S. L. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08630-4 · Cited by 1
Ascandar, N. E., Elgendi, K., Tarbay, A., Al-Qutbi, T., & Omar, S. A. (2026) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2026.117011 · Cited by 1
Tong, J., Cao, Y., Hanyu, Wang, W., Zhu, C., Yuan, H., Zhu, S., Lu, Y., & Zhu, L. (2026) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2026.06.012 · Cited by 2
New Obesity Definition and Clinical Obesity Prevalence for Global Metabolic Bariatric Surgery
Cremona, S., COHEN, R. V., Pattou, F., Casajoana, A., Souza, G. S., Raverdy, V., Verkindt, H., Blasio, B. T. L., Roser, P., Caiazzo, R., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.28395 · Cited by 1
Livingston, E. H. (2019) · JAMA · doi:10.1001/jama.2019.14577 · Cited by 1
Does Colectomy Improve Type 2 Diabetes?
Punchai, S., Wilson, R. L., Meister, K. M., Hanipah, Z. N., Vangoitsenhoven, R., Schauer, P. R., Steele, S. R., Hull, T. L., & Aminian, A. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04346-w · Cited by 1
“The powerful impact of bariatric surgery on obesity, glycemic control, and a host of other chronic conditions by altering gastrointestinal anatomy and physiology highlights the metabolic impact of these procedures [1, 2].”
BackgroundSelf-citationObesity Management and Prevention of Cardiovascular Disease
Gazda, C., & Almandoz, J. P. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_7 · Cited by 1
Bruno, J., Carruthers, D., & Alemán, J. O. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_8 · Cited by 1
Bariatric and Metabolic Surgery
Gagner, M., & Billmann, F. G. (2023) · Springer eBooks · doi:10.1007/978-3-662-66735-4_7 · Cited by 1
Mazaheri, T., Ansari, S., Nallagonda, M., Kollmann, L., Nickel, F., Seyfried, F., & Miras, A. D. (2023) · Die Chirurgie · doi:10.1007/s00104-023-01830-z · Cited by 2
Treatment of Severe Obesity—All-Hands-on-Deck Approach
Salminen, P. T. P., & Aminian, A. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.2931 · Cited by 1
Self-citationIntentional obesity reduction and the occurrence of gastric cancer – literature review
Gryta, J., Bielak, A., Iwan, K., Janczewska, M., Kania, K., Kalicka, M., Krysa, T., Kolasa, A., Radziejowska, Z., & Szklarz, M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.20.01.019 · Cited by 1
Remisión progresiva de antidiabéticos en pacientes obesos sometidos a cirugía bariátrica
Tamayo-Malusin, M. E., & Morales-Solís, J. M. (2024) · MQRInvestigar · doi:10.56048/mqr20225.8.1.2024.2418-2438
Pan, Y., Han, X., Tu, Y., Zhang, P., Yu, H., & Bao, Y. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07156-x · Cited by 1
“A recent study suggested that, compared to nonsurgical treatment, BS was associated with a significantly lower risk of incident major adverse cardiovascular events (MACE) in obese patients with type 2 diabetes (T2DM) [8].”
Midterm Outcome of Early Pregnancy Versus Late Pregnancy After Laparoscopic Sleeve Gastrectomy
Alqahtani, A. R., Almayouf, M., Butt, A., Bawahab, M. A., Billa, S., Maqsood, B., & Vergis, A. S. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07160-1 · Cited by 1
Beran, M., Ekstrom, H. L., Crain, A. L., Hooker, S. A., Chumba, L. N., Appana, D., Kromrey, K., Kunisetty, G., McKinney, Z. J., Pronk, N. P., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.107830 · Cited by 1
Vahtera, V., Pajarinen, J., Mika Kivimaki, B., Ervasti, J. M., Pentti, J., Stenholm, S., Vahtera, J., & Salminen, P. T. P. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000003993 · Cited by 1
Disease-Based Criteria vs BMI Level for Prioritization of Metabolic Surgery
Roser, P., McIntyre, R. D., Cremona, S., Assiri, A., Silva, L. B., Chamseddine, G., & Rubino, F. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07896-4 · Cited by 1
Impact of Metabolic Surgery on Cardiovascular Disease Outcomes
Piché, M., Poirier, P., & Wong, J. A. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.05.013 · Cited by 2
Woo, H., Kang, S. H., Baek, J. Y., Yoo, M., Park, Y. S., Kim, N., Lee, D. H., Kim, H., Shin, A., & Suh, Y. (2025) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000001479 · Cited by 1
Update on technologies, medicines and treatments
O’Neill, S. (2020) · Diabetic Medicine · doi:10.1111/dme.14229 · Cited by 1
Metabolic and bariatric surgery: diabetes - a decade of discovery
Veilleux, E., & Lutfi, R. E. (2020) · Mini-invasive Surgery · doi:10.20517/2574-1225.2020.01 · Cited by 1
Use of Pharmacotherapy in Obesity Management
Tham, K. W. (2021) · The Singapore Family Physician · doi:10.33591/sfp.47.5.u6 · Cited by 1
Bergeat, D., Blat, S., Gautier, Y., Guérin, S., Huërou‐Luron, I. L., Thibault, R., & Val‐Laillet, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-98575-8 · Cited by 1
Fat: bariatric surgery and procedures
McGowan, B. M. (2022) · British Journal of Diabetes · doi:10.15277/bjd.2022.368 · Cited by 1
Benefits of Mandated Registries for Generating Real-World Outcome Data
Salminen, P. T. P., Stenberg, E., & Batterham, R. L. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.1646 · Cited by 1
関東地方のタケカゴ細工の展開 : 日本列島におけるカゴ細工の諸系列(2)
中村, 俊. (1977) · 国立民族学博物館研究報告 · Cited by 1
Abril, C. M., & Corcelles, R. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.12.012 · Cited by 1
Mindre kardiovaskulær sykdom etter fedmekirurgi
Pettersen, P. M. (2019) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.19.0564
Billeter, A. T., Scheurlen, K. M., Probst, P., & Müller-Stich, B. P. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.01.024
Management of chronic diseases in preventive cardiology: Revisiting “the Problem of Obesity.”
Purnell, J. Q. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100005
Paired Editorial: Bariatric surgery is safe in patients with coronary artery disease
Murr, M. M. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.09.010
Reversión del Bypass Gástrico: Indicaciones y Resultados Quirúrgicos.
Besser, N., Gajardo, P. P. S., Tirado, P. A., Sanhueza, N. Q., Raddatz, A., Crovari, F. J., Blanco, G. P., Ricardo Mejía, M., Nervi, M. G., Julieta Klaassen, L., et al. (2021) · Revista de Cirugía · doi:10.35687/s2452-45492021005908
“La mediana de edad y del tiempo transcurrido desde la cirugía primaria hasta la reversión fue de 55 años (46-63) y de 77 meses (10-132), respectivamente.”
BackgroundKindel, T. L. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.02.020
Renal Complications After Bariatric Surgery
Wilson, R. L., & Aminian, A. (2021) · Springer eBooks · doi:10.1007/978-981-33-4702-1_10
Self-citationDuodenal Resurfacing for Treatment of Type 2 Diabetes
Hadefi, A., & Deviere, J. M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-29964-4_46-1
Bariatric surgery and kidney disease
Puzziferri, N., Friedman, A. N., & Wolfe, B. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00022-7
Friedman, A. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00007-0
Multimodal Care for Diabetes Combining Pharmacotherapy and Metabolic Surgery
Ansari, S., & Miras, A. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-54064-7_102-1
Metadata
- Authors
- Aminian, A., Zajichek, A., Arterburn, D. E., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Kattan, M. W., & Nissen, S. E.
- Affiliations
- Cleveland Clinic (US)
- Kaiser Permanente Washington Health Research Institute (US)
- Corresponding author
- Nissen, Steven E.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2019-10-01
- Volume
- 322
- Issue
- 13
- Pages
- 1271
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6724187
- OpenAlex
- W2970007463
- Cited by
- 505
- References
- 32
- Citations by year
- 2026: 61 · 2025: 71 · 2024: 68 · 2023: 73 · 2022: 66 · 2021: 83 · 2020: 73 · 2019: 9
- FWCI
- 55.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac, Anesthesia and Surgical Outcomes
- Keywords
- metabolic surgery, type 2 diabetes, obesity, major adverse cardiovascular events, cardiovascular outcomes, bariatric surgery, weight loss, myocardial infarction, ischemic stroke, heart failure, atrial fibrillation, kidney disease, mortality, cardiometabolic risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review